DBM Global Backlog Increase
DBM Global's adjusted backlog increased by approximately $300 million year-over-year to just over $1.3 billion, with an additional $400 million project expected to be added in the third quarter.
Life Sciences Revenue Surge
Life Sciences revenue increased by 88.2% to $3.2 million, driven by R2's increased Glacial Spa unit sales and consumable sales both inside and outside North America.
R2 Growth and Market Potential
R2's top line revenue increased to $3.2 million from $1.7 million in the previous year. Patient treatments grew by 115.1%, and average monthly utilization per provider increased by 28.5%. Social media engagements outperformed competitors by 823%.
Debt Refinancing Transactions
INNOVATE completed a series of refinancing transactions, reducing outstanding indebtedness by $27 million and extending debt maturities, enabling the continuation of strategic plans.